Navigation Links
New biotech company grows from MCG diabetes and genomic research
Date:7/19/2010

AUGUSTA, Ga. - A new biotech company has grown out of laboratory and clinical studies at the Medical College of Georgia with the goal of improving the diagnosis and treatment of diabetes and cancer.

Dr. Jin-Xiong She, director of the MCG Center for Biotechnology and Genomic Medicine, is president and CEO of the new Jinfiniti Biosciences LLC, housed in the MCG's Life Sciences Business Development Center, a turnkey incubator for these type of startup companies. Dr. Richard A. McIndoe, the center's associate director, is Jinfiniti's vice president for operations and information technology.

Jinfiniti provides a variety of high-throughput scientific services including nucleic acid isolation, genomic analysis, antibody production, immunoassays, medicinal chemistry and toxicity evaluation for academic and pharmaceutical institutions. The company also is developing biomarkers that will enable simple urine or blood tests for early disease detection and monitoring of treatment outcomes. Additionally, the company is developing new drugs and companion biomarkers for personalized medicine.

Dr. Charles Nawrot, MCG associate vice president for technology transfer and economic development, called She's company a logical outgrowth of his science which has focused on translational studies such as identifying high-risk genes for type 1 diabetes then studying in humans how they interact with the environment to cause disease.

"Dr. She's research is at the forefront of diagnosing and treating diabetes and cancer," Nawrot said. "Jinfiniti Biosciences will be the vehicle by which his biomarker discoveries will be made available to the public. Soon we will have patient-specific therapies that result from his research into the molecular basis of these diseases."

Moving laboratory findings into clinical practice is a major thrust of groups like the National Institutes of Health but the transition is a tough one, said She, Georgia Researc
'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert  

Page: 1 2

Related biology news :

1. $31 million biotech center to benefit crops, food, energy
2. Success with cisgenics in forestry offers new tools for biotechnology
3. Cutting-edge vaccine research to be showcased at AAPS National Biotechnology Conference
4. Biotherapeutic Innovations on Display at AAPS National Biotechnology Conference
5. AAPS immunogenicity training course to be offered prior to national biotechnology conference
6. UT Southwesterns BioCenter driving biotech, medical innovation in North Texas
7. NYU School of Medicine presents biomedical researchers Dart/NYU Biotechnology Achievement Awards
8. GenWay Biotech extends the You Test You program overseas
9. New biotech advance to add heart healthy omega-3s to US diet
10. McGill, Quebec biotech firm partner for new bone-disease treatment
11. GenWay Biotechs You Test You puts early cancer detection tool in the hands of consumers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New biotech company grows from MCG diabetes and genomic research
(Date:9/17/2014)... care to reproductive technologies, the justice and well-being ... people to identify key issues, articulate their values ... the most defensible ways forward. But what are ... conversations?, The Hastings Center and the Presidential Commission ... up to publish a series of essays to ...
(Date:9/17/2014)... atmospheric scientists were instrumental in the creation of the ... to classify the fire threat potential of the powerful, ... spark into an inferno. The index was introduced Sept. ... UCLA and San Diego Gas and Electric. , The ... "extreme" that will be used to help fire agencies ...
(Date:9/17/2014)... Humanities has received a $260,000 grant from the Andrew ... of the Human in the Age of the Life ... of events aimed at exploring two compelling themes in ... who are exploring the boundaries of our self-definition as ... other involves the increasingly influential hypothesis that we are ...
Breaking Biology News(10 mins):Why bioethics literacy matters 2Why bioethics literacy matters 3UCLA scientists play key role in developing new Santa Ana Wildfire Threat Index 2Mellon Foundation awards grant for major project in the humanities and sciences 2
... Research led by T. Cooper Woods, PhD, Assistant Professor ... Center New Orleans, and Director of the Molecular Cardiology ... mechanism of how a drug commonly used on stents ... movement which is critical to wound healing and the ...
... TORONTO (April 13, 2010) -- An investigational intervention using ... thinking abilities of a group of mild- to moderate-stage ... rate of atrophy (shrinkage) of their brains, according to ... Center. These and other findings from the Phase II ...
... the Department of Computer Science at Virginia Tech have used ... by scientists in their quest to define the microbial DNA ... computers from across the world, the mpiBLAST computational tool used ... 90 years it would have required if the work were ...
Cached Biology News:Research discovery may lead to advances in heart disease and cancer treatment 2Investigational immune intervention slows brain shrinkage in Alzheimer's patients 2Investigational immune intervention slows brain shrinkage in Alzheimer's patients 3Investigational immune intervention slows brain shrinkage in Alzheimer's patients 4High-performance computing reveals missing genes 2High-performance computing reveals missing genes 3
(Date:9/17/2014)... INCLINE VILLAGE, Nev. , Sept. 17, 2014  PDL ... notified by its independent registered accounting firm, Ernst & Young ... The resignation was confirmed in a letter delivered to the ... 8-K filed on September 16, 2014.  PDL ... "We have received a number of inquiries on ...
(Date:9/17/2014)... SAN FRANCISCO , Sept. 17, 2014 /PRNewswire/ ... patients receiving accelerated partial breast irradiation (APBI) via ... and those with positive lymph nodes could be ... for Radiation Oncology (ASTRO) guidelines place these patients ... an abstract at the 2014 ASTRO meeting, Beaumont ...
(Date:9/17/2014)... 17, 2014 The global consumption of squalene / ... is a natural skin-identical chemical that finds applications in various ... supplements, pharmaceuticals, and in other applications like high grade lubrication, ... a few major players and is regionally segregated. Sophim ( ... Oil Co. Ltd. ( Japan ), SeaDragon Marine ...
(Date:9/17/2014)... SEATTLE, WA , Sept. 17, 2014 /PRNewswire/ - ... that it intends to offer and sell shares of ... in separate but concurrent underwritten public offerings.  The Series ... shares of Oncothyreon Common Stock, provided that conversion will ... its affiliates would beneficially own more than 4.99% of ...
Breaking Biology Technology:PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 2Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 3Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 4Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3Oncothyreon Announces Proposed Public Offerings 2
... Sept. 26 MacroGenics, Inc. announced,today that Mr. ... of the,company,s Board of Directors. With more than ... in the pharmaceutical and,biotechnology industry, Mr. Buchalter is ... MacroGenics as the company matures toward,commercializing its pipeline. ...
... XTL,Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: ... 2007, the Company received a NASDAQ Staff,Determination indicating ... minimum,$10 million shareholders, equity requirement for continued listing ... Marketplace Rule 4450(a)(3), and that,its ADRs are, therefore, ...
... Empowers Life Sciences Community with accelerated BioInformatics, ... Corp., announced,the initiation of Progeniq Pte Ltd, ... Singapore, into the BioIT Alliance today. The,BioIT ... integrate science and,technology to accelerate the pace ...
Cached Biology Technology:Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman 2Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman 3XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market 2XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market 3Progeniq Joins Microsoft in Bio IT Alliance 2Progeniq Joins Microsoft in Bio IT Alliance 3
...
... The Bio-Plex maintenance, calibration, ... is a custom 96-well plate ... validation, and calibration procedures using ... This MCV plate is for ...
Mynox is intended for research use only. Mynox is used for the elimination of Mycoplasma and Acholeplasma in cell and virus cultures, and other biologicals....
... PCR detection system holds 48 x 0.2 ml ... 48 LEDs independently excites fluorescence (470-500 nm) for ... detects emitted light (523-543 nm and 540-700 nm). ... cycler, whose Peltier heat pumps provide superb thermal ...
Biology Products: